Review
Copyright ©The Author(s) 2015.
World J Exp Med. May 20, 2015; 5(2): 110-119
Published online May 20, 2015. doi: 10.5493/wjem.v5.i2.110
Figure 1
Figure 1 In non-diabetic patients, L-arginine by far outweighs asymmetric dimethylarginine, and active nitrogen oxide modulates vascular tone and structure. DDAH: Dimethylarginine dimethylaminohydrolase; ADMA: Asymmetric dimethylarginine; LDL: Low-density lipoprotein; NO: Nitrogen oxides.